Micro-dystrophin gene constructs for repairing heart and muscle function in rats: the smaller is enough?
- PMID: 35449294
- DOI: 10.1038/s41434-022-00337-2
Micro-dystrophin gene constructs for repairing heart and muscle function in rats: the smaller is enough?
Comment on
-
Evaluation of the dystrophin carboxy-terminal domain for micro-dystrophin gene therapy in cardiac and skeletal muscles in the DMDmdx rat model.Gene Ther. 2022 Sep;29(9):520-535. doi: 10.1038/s41434-022-00317-6. Epub 2022 Feb 1. Gene Ther. 2022. PMID: 35105949
References
-
- Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A. Duchenne muscular dystrophy. Nat Rev Dis Primers. 2021;7:13. - DOI
-
- Muntoni F. Cardiomyopathy in muscular dystrophies. Curr Opin Neurol. 2003;16:577–83. - DOI
-
- Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010;9:77–93. - DOI
-
- Goemans N, Buyse G. Current treatment and management of dystrophinopathies. Curr Treat Options Neurol. 2014;16:287. - DOI
-
- Chamberlain JR, Chamberlain JS. Progress toward gene therapy for Duchenne muscular dystrophy. Mol Ther. 2017;25:1125–31. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources